Keeren Shah
Director of Finance/CFO at ACTAVIA LIFE SCIENCES, INC.
Net worth: 88 $ as of 2024-03-30
Profile
Keeren Shah is currently working as a Member at The Chartered Institute of Management Accountants.
Additionally, Ms. Shah holds the position of Chief Financial Officer at OKYO Pharma Ltd., Actavia Life Sciences, Inc., AccuStem Sciences, Inc., and Tiziana Life Sciences Ltd.
In the past, Ms. Shah worked as a Finance Director at Rasna Therapeutics, Inc.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
ACCUSTEM SCIENCES INC
0.00% | 2022-12-30 | 250 ( 0.00% ) | 88 $ | 2024-03-30 |
Keeren Shah active positions
Companies | Position | Start |
---|---|---|
ACTAVIA LIFE SCIENCES, INC. | Director of Finance/CFO | 2020-07-30 |
OKYO PHARMA LIMITED | Director of Finance/CFO | 2020-07-31 |
ACCUSTEM SCIENCES, INC. | Director of Finance/CFO | 2021-07-31 |
TIZIANA LIFE SCIENCES LTD | Director of Finance/CFO | - |
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Corporate Officer/Principal | - |
Former positions of Keeren Shah
Companies | Position | End |
---|---|---|
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
OKYO PHARMA LIMITED | Health Technology |
ACTAVIA LIFE SCIENCES, INC. | Health Technology |
ACCUSTEM SCIENCES, INC. | Health Technology |
TIZIANA LIFE SCIENCES LTD | Health Technology |
Private companies | 2 |
---|---|
The Chartered Institute of Management Accountants
The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services The Chartered Institute of Management Accountants, also known as aicpa® & cima®, is a global organization with 689,000 members, students, and professionals. The non-profit company is based in London, UK, and has a global presence of subsidiaries in several regions. The British company advocates for the accounting and finance profession, as well as the public interest and business sustainability. Andrew Harding has been the CEO of the company since 2009. | Consumer Services |
Rasna Therapeutics, Inc. /Old/
Rasna Therapeutics, Inc. /Old/ Medical DistributorsDistribution Services Rasna Therapeutics, Inc. operates as a development stage biotechnology company focused on the development of cancer drugs. It is focused primarily on the development of drug candidates for leukemia and lymphoma. The company was founded by Gabriele Marco Antonio Cerrone, Roberto Pellicciari and Brunangelo Falini in 2013 and is headquartered in San Diego, CA. | Distribution Services |
- Stock Market
- Insiders
- Keeren Shah